Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
United States Oil Fund LP
USO
US Stock MarketDetailed Quotes
Ligand Pharmaceuticals (LGND)
- 280.180
- -6.110-2.13%
Close Aug 24 16:00 ET
- 280.180
- 0.0000.00%
Post 19:30 ET
5.59BMarket Cap28.85P/E (TTM)
286.270High279.870Low158.24KVolume286.270Open286.290Prev Close44.59MTurnover0.81%Turnover Ratio45.71P/E (Static)19.94MShares326.63052wk High5.77P/B5.46BFloat Cap160.80052wk Low--Dividend TTM19.48MShs Float326.630Historical High--Div Yield TTM2.24%Range %4.115Historical Low281.772Avg Price1Lot Size
Ligand Pharmaceuticals (LGND) Key Financial Indicators
LGND Earnings per Share (EPS)
According to the latest financial report of Ligand Pharmaceuticals, the latest earnings per share (TTM) for the company is 2.22. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
LGND Free Cash Flow (FCF)
Interested in knowing about Ligand Pharmaceuticals's free cash flow? The latest report shows it as 21.35M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
LGND Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ligand Pharmaceuticals shows that the company's current ratio is 31.18, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
LGND Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ligand Pharmaceuticals, the quick ratio is 30.83, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
LGND Return on Equity (ROE)
Want to learn more about the financial health of Ligand Pharmaceuticals? The latest ROE figure is 4.94%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
LGND Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ligand Pharmaceuticals, the total asset return on investment (ROA) is 2.61%.
Currency: USD
Quarterly
Loading...
LGND Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ligand Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 94.95%.
Currency: USD
Quarterly
Loading...
LGND Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ligand Pharmaceuticals, the net profit margin is 76.16%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm